Medicare billing address
CMS Medicare provider billing file
120 E 2Nd St Fl 2Erie, PA 16507
CMS public data · NPI 1235133281
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Kelly L Hayes, MD
Specialty
Credential
MD
NPI
1235133281
Primary source state
PA
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Kelly L Hayes, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
120 E 2Nd St Fl 2CMS Doctors & Clinicians file
120 E 2Nd StCMS Doctors & Clinicians file
201 State StCMS Doctors & Clinicians file
201 State StIn the 2024 CMS provider billing file, this NPI had 1,672 Medicare beneficiaries and 5,060 total services. The average beneficiary age was 76, and the average HCC risk score was 1.6.
Total Medicare allowed amount
$280,332.29
Total Medicare payment amount
$205,741.97
Medicare beneficiaries
1,672
Total services
5,060
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Atrial fibrillation
63%
CMS beneficiary-panel share
Ischemic heart disease
48%
CMS beneficiary-panel share
Heart failure
42%
CMS beneficiary-panel share
Diabetes
37%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Anticoagulant management of patient taking warfarin | 1,674 | $10.75 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 387 | $119.18 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 365 | $19.43 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 261 | $15.56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 236 | $27.84 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 205 | $91.48 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 133 | $34.58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 132 | $7.58 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 131 | $74.00 |
| Programming of dual lead pacemaker system | 120 | $73.09 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1235133281. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Eliquis | Apixaban | 1,326 | 2,649.4 | $1,492,025.64 |
| 2 | Metoprolol Succinate | Metoprolol Succinate | 646 | 1,736.1 | $9,931.59 |
| 3 | Xarelto | Rivaroxaban | 395 | 888 | $477,062.93 |
| 4 | Amiodarone Hcl | Amiodarone Hcl | 385 | 971.1 | $5,379.54 |
| 5 | Metoprolol Tartrate | Metoprolol Tartrate | 357 | 874.2 | $2,481.39 |
| 6 | Warfarin Sodium | Warfarin Sodium | 338 | 890.3 | $3,574.48 |
| 7 | Diltiazem 24Hr Er (Cd) | Diltiazem Hcl | 298 | 747.6 | $6,826.96 |
| 8 | Flecainide Acetate | Flecainide Acetate | 184 | 456.5 | $9,149.91 |
| 9 | Atorvastatin Calcium | Atorvastatin Calcium | 155 | 415.8 | $1,429.08 |
| 10 | Carvedilol | Carvedilol | 145 | 360.7 | $1,455.67 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Vermont College Of Medicine
Graduation year
1995
Group/practice field
Regional Health Services Inc
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.